Medifast, Inc. (MED) Stock Price & Analysis
Medifast, Inc. (MED) closed at USD 12.06 on Thursday, October 15, 2026, up 1.77% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 11.85; the Oct 15, 2026 session ranged USD 11.95–12.37 on volume of 119,426 shares. Market capitalization is $134.84M, with a 52-week range of USD 9.22–13.58 (NYQ). Source: Nexqual, retrieved October 16, 2026 at 05:19 UTC.
Also available as compact Markdown for AI agents: nexqual.com/MED.md
Key facts (MED)
- Analysts: Hold (mean 3.00 on a 1–5 scale) (1 analysts), mean target USD 12 (range 12–12).
- Total return with dividends: 1Y -6.2% vs S&P 500 +18.1%; 5Y -93.0% vs S&P 500 +85.1%.
- Next earnings: 2026-10-26, EPS estimate USD -0.35, revenue estimate $71.3M.
Analysts (MED)
Consensus Hold (mean 3.00 on a 1–5 scale), 1 analysts; mean target USD 12 (low 12, high 12).
Total return (dividends reinvested) (MED)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | -6.2% | -93.0% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -6.2% | -41.1% |
| Volatility (annualized) | 49.6% | 44.3% |
| Max drawdown | -28.1% (May 2026→Jul 2026) | -95.3% (Nov 2021→Mar 2026) |
Key Statistics (as of October 16, 2026 at 05:19 UTC)
| Price | USD 12.06 |
|---|---|
| Change | ▲ 1.77% (up) |
| Previous Close | USD 11.85 |
| Open | USD 11.91 |
| Day Range | USD 11.95 – 12.37 |
| 52-Week Range | USD 9.22 – 13.58 |
| Volume | 119,426 shares |
| Market Cap | $134.84M |
| Exchange | NYQ |
Technical Analysis (MED)
Nexqual's technical model rates MED "BUY" based on 4 bullish and 1 bearish signals across 127 daily candles, as of October 16, 2026 at 05:19 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 56.52 (neutral) |
| vs SMA50 | Above (USD 11.9) |
| MACD | -0.03 (negative) |
Analyst Ratings (MED)
Wall Street analysts rate MED "Hold" based on 1 analysts, with a mean price target of USD 12 (range USD 12–12), per Nexqual as of October 16, 2026 at 05:19 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 12 |
| High Target | USD 12 |
| Low Target | USD 12 |
| Buy / Hold / Sell | 0 / 1 / 0 |
Earnings (MED)
| Next Earnings Date | 2026-10-26 |
|---|---|
| EPS Estimate | USD -0.35 |
| Revenue Estimate | $71.30M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.28 vs est -0.65 ▲ beat |
| 2026-03-31 | USD -0.19 vs est -0.52 ▲ beat |
| 2025-12-31 | USD -1.65 vs est -0.82 ▼ miss |
| 2025-09-30 | USD -0.21 vs est -0.36 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:19 UTC.
Financials & Fundamentals (MED)
| Total Revenue | $316.93M |
|---|---|
| Revenue Growth (latest quarter, YoY) | -27.60% |
| Gross Margin | +69.24% |
| Operating Margin | -5.66% |
| Profit Margin | -8.08% |
| ROE | -12.42% |
| Debt / Equity | 0.14 |
| Current Ratio | 4.86 |
| Total Cash | $169.82M |
| Total Debt | $27.62M |
Source: Nexqual, October 16, 2026 at 05:19 UTC.
Financial Health Score (MED)
Nexqual rates Medifast, Inc.'s overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:19 UTC.
| Growth | Critical — Revenue -44% YoY (annual), sharp decline |
|---|---|
| Profitability | Solid — Gross margin 69%, operating -6% |
| Balance Sheet | Strong — $170M cash vs $28M debt, net cash position |
| Cash Flow | Solid — Operating cash flow $9M (TTM) |
| Efficiency | Critical — ROE -12%, ROA -4.6% |
Ownership (MED)
| Insider Ownership | +4.33% |
|---|---|
| Institutional Ownership | +75.08% |
| Shares Outstanding | 11.18M |
| Float | 8.46M |
| Short % of Float | +9.76% |
Source: Nexqual, October 16, 2026 at 05:19 UTC.
Leadership (MED)
Medifast, Inc. is led by Nicholas M. Johnson (age 45), CEO & President, per Nexqual as of October 16, 2026 at 05:19 UTC.
| CEO & President | Nicholas M. Johnson (age 45) |
|---|---|
| Chief Financial Officer | James P. Maloney (age 57) |
| Vice President of Investor Relations | Steven Zenker |
Major Backers & Investors (MED)
Notable institutional backers of Medifast, Inc. include Renaissance Technologies, Steamboat Capital Partners, Llc, American Century Companies Inc, according to Nexqual as of October 16, 2026 at 05:19 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Renaissance Technologies | 6.96% |
| Steamboat Capital Partners, Llc | 6.32% |
| American Century Companies Inc | 6.28% |
| Two Sigma Investments, LP | 4.31% |
| Charles Schwab | 3.98% |
| Charles Schwab Investment Management, Inc. | 3.55% |
| Morgan Stanley | 2.62% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 9.04% |
| BlackRock | 4.4% |
| Dimensional Fund Advisors | 3.79% |
Source: Nexqual, October 16, 2026 at 05:19 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CSV | Carriage Services, Inc. | USD 36.13 | ▲ 4.39% |
| ANDG | Andersen Group Inc. | USD 58.95 | ▲ 1.53% |
| BFAM | Bright Horizons Family Solution | USD 70.42 | ▲ 3.3% |
| FTDR | frontdoor, inc. | USD 78.26 | ▲ 0.55% |
| HRB | H&R Block, Inc. | USD 48.31 | ▲ 10.22% |
| SCI | Service Corporation Internation | USD 80.83 | ▲ 3.85% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:19 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt